New Zealand markets closed

ImmuCell Corporation (ICCC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
5.02-0.01 (-0.20%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.03
Open5.05
Bid0.00 x 0
Ask0.00 x 0
Day's range5.02 - 5.12
52-week range4.26 - 6.05
Volume2,877
Avg. volume7,826
Market cap38.909M
Beta (5Y monthly)0.60
PE ratio (TTM)N/A
EPS (TTM)-0.75
Earnings date09 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

    PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited sales results for the first quarter of 2024, which ended March 31, 2024. Preliminary, Unaudited Total Sales Results: 20242023$ Increase % IncreaseDuring the T

  • Insider Monkey

    ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript

    ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript February 28, 2024 ImmuCell Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the ImmuCell Corporation reports Fourth Quarter and Year Ended December 31, 2023 Unaudited Financial […]

  • GlobeNewswire

    ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

    PORTLAND, Maine, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter and year ended December 31, 2023. Management’s Discussion: “Our unaudited, preliminary product sales for the fourth quarter of 2023 we